Company: NYXH
Filing Date: 2025-09-15
Form Type: 6-K
Source: 0001104659-25-090018
Chunk: 1

Company: Nyxoah SA
Filing Date: 2025-09-15
Form: 6-K
Chunk 1
---
99.1 and is incorporated herein by reference.

Inspire Patent Infringement Lawsuit

The Company filed a patent infringement lawsuit
against Inspire Medical Systems, Inc. alleging that the Inspire IV and Inspire V devices infringe the following three patents held by
the Company: U.S. Patent Nos. 8,700,183, 9,415,215, and 9,415,216. The suit was filed in the United States District Court for the District
of Delaware, seeking injunctive relief and damages for infringement.

The information in the attached Exhibit 99.1 is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

The information included under the heading “Inspire Patent Infringement Lawsuit” shall be deemed to be incorporated by reference into the registration statements on Form S-8 (Registration Numbers 333-285960, 333-283103, 333-261233 and 333-269410) and Form F-3 (Registration Numbers 333-268955 and 333-285982) of the Company (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

<div align='center'>2</div>

Exhibits

<div align='center'>3

SIGNATURES</div>

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| Date: September 15, 2025 | NYXOAH SA 
 By:       | /s/ John Landry         |
|:-------------------------|:----------|:------------------------|
|                          | Name:     | John Landry             |
|                          | Title:    | Chief Financial Officer |

<div align='center'>4</div>